Sanofi’s third Translate collaboration sees big bucks at last
The deal-hungry French big pharma gives Translate’s mRNA vaccine technology a massive boost.
Gilead opts not to buy Arcus
Arcus insists that its new partnership is a good deal, but shareholders make their feelings known.
Big Pharma throws out old models in the race to a Covid-19 vaccine
From research collaborations to changes to drug development, pharma will have to find new ways of working to discover Covid-19 treatments.
